SecProbe.io

CORRESP
1
filename1.htm

 February 4, 2025

Via
Edgar Transmission

Mr.
Alan Campbell / Ms. Doris Stacey Gama

Division
of Corporation Finance

Office
of Life Sciences

U.S.
Securities and Exchange Commission

100
F Street, N.E.

Washington,
DC 20549

    Re:
    Cuprina
    Holdings (Cayman) Limited

    Amendment
    No. 1 to Registration Statement on Form F-1

    Filed
    on January 7, 2024

    File
    No. 333-283643

Dear
SEC Officers:

On
behalf of our client, Cuprina Holdings (Cayman) Limited, a foreign private issuer organized under the laws of the Cayman Islands (the
“Company”), we are filing herewith the Company’s registration statement on Form F-1 (the “Registration
Statement”) and certain exhibits via EDGAR to the Securities and Exchange Commission (the “Commission”).

Concurrently
with the filing of the Registration Statement, the Company is hereby in this letter setting forth the Company’s responses to the
comments contained in the letter from the staff of the Commission (the “Staff”) dated January 14, 2025 on the Company’s
Registration Statement filed on January 7, 2024.

The
Staff’s comments are repeated below in bold and are followed by the Company’s responses. We have included page references
in the Registration Statement where the language addressing a particular comment appears. Capitalized terms used but not otherwise defined
herein have the meanings set forth in the Registration Statement.

Amendment
No. 1 to Registration Statement on Form F-1

Management

Compensation
of Directors and Executive Officers, page 140

    1.
    Please
    revise this section to provide compensation information for the year ended December 31, 2024.

Response:
In response to the Staff’s comment, the Company has amended the relevant disclosures on page 140 of the Registration Statement.

Exhibits

    2.
    Please
    revise the legal opinion filed as Exhibit 5.1 to cover the Representative’s Warrants.

Response:
In response to the Staff’s comment, we have filed a legal opinion from Loeb & Loeb LLP as exhibit 99.6 to cover the legality
of the Representative’s Warrants.

If
you have any questions regarding the Registration Statement, please contact the undersigned by phone at +1 310 7285129 or via email at
lvenick@loeb.com.

    Very
    truly yours

    By:
    /s/
    Lawrence Venick

    Lawrence
    Venick

    Partner

    cc:
    David
    Quek Yong Qi, Director and Chief Executive Officer, Cuprina Holdings (Cayman) Limited

    Chan
    Tat Jing, Financial Controller, Cuprina Holdings (Cayman) Limited

    Michael
    J. Blankenship, Esq., Winston & Strawn LLP